Yan-Xia Zhang1, Jian-Rong Zhang, Zhi-Gang Wang. 1. Department of Nephropathy, Affiliated Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Abstract
BACKGROUND: Mycophenolate mofetil (MMF) has been used to prevent transplant rejection for many years and has been shown to have protective effects against renal failure. The objective was to investigate the effect of MMF on monocyte Toll-like receptor 4 (TLR4) signaling in the early stages of renal ischemia/reperfusion injury (IRI) of mice. METHODS: Sixty BALB/C mice were randomly divided into two groups: an IRI group, in which renal IRI was induced by clamping the renal pedicles for 45 minutes, and an MMF group, in which MMF was given (40 mg×kg(-1)×d(-1), intraperitoneally) from 2 days before renal IRI. The plasma creatinine level and renal tissue damage of each group mice were observed 6, 12, 24, and 48 hours after reperfusion. The concentration of plasma high-mobility group box 1 (HMGB-1) (TLR4 ligand), interleukin 6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor α (TNF-α) and the expression of TLR-4 on monocytes were determined. RESULTS: The plasma creatinine concentration in the MMF group was lower compared to the IRI group (after reperfusion of 6, 12, 24, or 48 hours, P < 0.05). Pathological analysis showed that the renal damage was slighter, TLR-4 expression was reduced (after reperfusion of 6, 12, 24, or 48 hours, P < 0.05), and the concentration of cytokines in the plasma was lower (P < 0.05) in the MMF group. No differences in the concentrations of HMGB-1 were observed (P > 0.05). CONCLUSION: Monocyte TLR4 signaling is important in the early stage of kidney IRI, but MMF can inhibit it and improve renal function.
BACKGROUND:Mycophenolate mofetil (MMF) has been used to prevent transplant rejection for many years and has been shown to have protective effects against renal failure. The objective was to investigate the effect of MMF on monocyte Toll-like receptor 4 (TLR4) signaling in the early stages of renal ischemia/reperfusion injury (IRI) of mice. METHODS: Sixty BALB/C mice were randomly divided into two groups: an IRI group, in which renal IRI was induced by clamping the renal pedicles for 45 minutes, and an MMF group, in which MMF was given (40 mg×kg(-1)×d(-1), intraperitoneally) from 2 days before renal IRI. The plasma creatinine level and renal tissue damage of each group mice were observed 6, 12, 24, and 48 hours after reperfusion. The concentration of plasma high-mobility group box 1 (HMGB-1) (TLR4 ligand), interleukin 6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor α (TNF-α) and the expression of TLR-4 on monocytes were determined. RESULTS: The plasma creatinine concentration in the MMF group was lower compared to the IRI group (after reperfusion of 6, 12, 24, or 48 hours, P < 0.05). Pathological analysis showed that the renal damage was slighter, TLR-4 expression was reduced (after reperfusion of 6, 12, 24, or 48 hours, P < 0.05), and the concentration of cytokines in the plasma was lower (P < 0.05) in the MMF group. No differences in the concentrations of HMGB-1 were observed (P > 0.05). CONCLUSION: Monocyte TLR4 signaling is important in the early stage of kidney IRI, but MMF can inhibit it and improve renal function.
Authors: Gianluigi Zaza; Jeremy Leventhal; Lorenzo Signorini; Giovanni Gambaro; Paolo Cravedi Journal: Front Immunol Date: 2019-12-19 Impact factor: 7.561
Authors: Amanda Helen Albino; Fernanda Florencia Fregnan Zambom; Orestes Foresto-Neto; Karin Carneiro Oliveira; Victor Ferreira Ávila; Simone Costa Alarcon Arias; Antonio Carlos Seguro; Denise Maria Avancini Costa Malheiros; Niels Olsen Saraiva Camara; Clarice Kazue Fujihara; Roberto Zatz Journal: Front Physiol Date: 2021-07-07 Impact factor: 4.566
Authors: Safaa I Tayel; Nashwa M Muharram; Dina S Fotoh; Hany S Elbarbary; Huda I Abd-Elhafiz; Eman A El-Masry; Ahmed E Taha; Shimaa E Soliman Journal: Biomolecules Date: 2021-09-18